Literature DB >> 24528173

The relationship between neutrophil/lymphocyte ratio and calcific aortic stenosis.

Anil Avci1, Alizade Elnur, Acar Göksel, Fidan Serdar, Izci Servet, Koyuncu Atilla, Tabakcı Mehmet Mustafa, Toprak Cuneyt, Guler Yeliz, Bulut Mustafa, Esen Ali Metin.   

Abstract

BACKGROUND: The role of inflammation in fibrotic and calcific processes of atherosclerosis and aortic stenosis (AS) is similar. Furthermore, a relationship between systemic inflammation and heart failure has been well demonstrated. Recently, neutrophil/lymphocyte ratio (NLR) has been proposed as a predictive marker of systemic inflammation. We investigated the association of NLR with the severity of calcific AS and left ventricular (LV) systolic dysfunction in patients with severe calcific AS.
METHODS: A total of 96 patients with calcific AS were included in this retrospective study from 2011 to 2013. The severity of AS was graded according to the transaortic mean pressure gradient. The patients were divided into 3 groups as mild-to-moderate AS, severe AS with normal left ventricular ejection fraction (LVEF), and severe AS with reduced LVEF (mean gradient >40 mmHg and LVEF <50%).
RESULTS: Neutrophil/lymphocyte ratio was significantly higher in severe calcific AS with reduced LVEF group than the other 2 groups (3.94 ± 0.88, P < 0.001). In addition, NLR was higher in severe AS with normal LVEF group than mild-to-moderate AS group (2.69 ± 1.00 vs. 2.05 ± 0.64, P = 0.008). There was a statistically significant correlation between NLR and both transaortic mean pressure gradient and aortic valve peak velocity in patients with mild-to-severe AS with normal LVEF (n = 81; r = 0.369, P < 0.001; r = 0.290, P = 0.004; respectively).
CONCLUSION: Increased NLR is related to the severity of calcific AS and LV systolic dysfunction in patients with severe calcific AS.
© 2014, Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic stenosis; echocardiography; heart failure

Mesh:

Year:  2014        PMID: 24528173     DOI: 10.1111/echo.12534

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  10 in total

1.  Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis.

Authors:  Jun Teishima; Shinya Ohara; Kousuke Sadahide; Shinsuke Fujii; Hiroyuki Kitano; Kohei Kobatake; Shunsuke Shinmei; Keisuke Hieda; Shogo Inoue; Tetsutaro Hayashi; Koji Mita; Akio Matsubara
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

Review 2.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 3.  Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

Authors:  Wieteke Broeders; Siroon Bekkering; Saloua El Messaoudi; Leo A B Joosten; Niels van Royen; Niels P Riksen
Journal:  Basic Res Cardiol       Date:  2022-05-17       Impact factor: 12.416

4.  Value of neutrophil to lymphocyte ratio as a predictor of mortality in patients undergoing aortic valve replacement.

Authors:  Mirette Habib; Mohammad Thawabi; Amer Hawatmeh; Habib Habib; Walid ElKhalili; Fayez Shamoon; Medhat Zaher
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

5.  Predictive value of platelet-to-lymphocyte ratio in severe degenerative aortic valve stenosis.

Authors:  Efe Edem; Hasan Reyhanoğlu; Murat Küçükukur; Ali Hikmet Kırdök; Ahmet Ozan Kınay; Ümit İlker Tekin; Kaan Özcan; Murat Ertürk; Çağın Şentürk; Bahadır Kırılmaz; Hasan Güngör; İsa Durmaz
Journal:  J Res Med Sci       Date:  2016-10-18       Impact factor: 1.852

6.  Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease.

Authors:  Shuai Guo; Erli Zhang; Bin Zhang; Qingrong Liu; Zhen Meng; Ziang Li; Can Wang; Zhaoting Gong; Yongjian Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-29

7.  What is the clinical benefit of neutrophil-lymphocyte ratio in cardiovascular patients?

Authors:  Yavuzer Koza
Journal:  J Cardiovasc Thorac Res       Date:  2014-06-30

8.  Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis.

Authors:  Kyoung Im Cho; Sang Hoon Cho; Ae-Young Her; Gillian Balbir Singh; Eun-Seok Shin
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

9.  In Paroxysmal Atrial Fibrillation Patients, the Neutrophil-to-lymphocyte Ratio Is Related to Thrombogenesis and More Closely Associated with Left Atrial Appendage Contraction than with the Left Atrial Body Function.

Authors:  Yukihiro Fukuda; Mitsunori Okamoto; Shunsuke Tomomori; Hiroya Matsumura; Takehito Tokuyama; Yukiko Nakano; Yasuki Kihara
Journal:  Intern Med       Date:  2017-11-20       Impact factor: 1.271

10.  Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE).

Authors:  Marwa Sayed Meshaal; Abdo Nagi; Ahmed Eldamaty; Wae'el Elnaggar; Mervat Gaber; Hussien Rizk
Journal:  Egypt Heart J       Date:  2019-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.